FPH — Fisher & Paykel Healthcare Cashflow Statement
0.000.00%
- NZ$21.88bn
- NZ$21.77bn
- NZ$2.02bn
- 100
- 9
- 99
- 78
Annual cashflow statement for Fisher & Paykel Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | NZAS | NZAS | NZAS | NZAS | NZAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 1.5 | 2.1 | 2.8 | 3.2 | 3.9 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 625 | 324 | 238 | 430 | 549 |
Capital Expenditures | -185 | -170 | -211 | -339 | -103 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -203 | 80.3 | 200 | 0 | — |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -387 | -89.5 | -11.3 | -339 | -103 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -188 | -236 | -197 | -129 | -268 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 49 | -0.8 | 32.2 | -35.9 | 179 |